Enclomiphene Citrate: What People Actually Pay

Why Enclomiphene Has No Standard Retail Price

Enclomiphene citrate is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) that has been used off-label for male hypogonadism for decades 1. The racemic mixture (Clomid) contains both enclomiphene (the active anti-estrogenic isomer) and zuclomiphene, which carries estrogenic activity and a longer half-life 2. Repros Therapeutics pursued FDA approval for enclomiphene under the brand name Androxal, but the agency issued a Complete Response Letter in 2015 citing concerns about the assay used in key trials 3.

Because no branded product reached market, enclomiphene exists in a regulatory gray zone. Compounding pharmacies can legally prepare it under section 503A or 503B of the Federal Food, Drug, and Cosmetic Act 4, but there is no National Drug Code (NDC) tied to a commercial manufacturer. That missing NDC is precisely why insurance formularies exclude it. Patients pay cash, and cash prices depend on the pharmacy, the state, and the prescriber's preferred supplier.

Compounding Pharmacy Prices: The $30 to $90 Range

The most affordable route is a direct prescription to a compounding pharmacy. Patient reports on Reddit's r/Testosterone and r/Trt communities consistently cite monthly costs between $30 and $90 for a 30-day supply of 25 mg capsules 5. One frequently referenced 503B outsourcing facility, Help Pharmacy, has listed enclomiphene citrate 12.5 mg and 25 mg capsules at roughly $45 to $65 for 30 capsules, though pricing shifts quarterly.

Factors that move the price within this band include capsule strength (12.5 mg vs. 25 mg vs. 50 mg), quantity dispensed (30 vs. 90 count), and whether the pharmacy charges a dispensing fee. The American Association of Clinical Endocrinology (AACE) guidelines on male hypogonadism note that SERMs can be a cost-effective alternative to exogenous testosterone when fertility preservation matters 6. That recommendation, combined with rising demand from younger men, has pushed more pharmacies into the enclomiphene space and driven incremental price competition.

A practical warning: not all compounding pharmacies source pharmaceutical-grade enclomiphene powder. The FDA has issued warning letters to compounders using unapproved bulk drug substances 4. Patients should verify that their pharmacy holds current state licensure and, ideally, PCAB accreditation.

Telehealth Platform Pricing: Convenience at a Premium

Telehealth men's health clinics have made enclomiphene their flagship offering for fertility-preserving testosterone optimization. Monthly subscription costs at these platforms typically run $99 to $199, which bundles the provider consultation, lab monitoring, and the medication itself 7.

The premium over a standalone compounding pharmacy fill reflects the consultation fee, lab coordination, and platform overhead. For men who already have an endocrinologist or urologist willing to prescribe, going directly to a compounding pharmacy saves $50 to $100 per month. For men without an existing provider relationship, the all-in telehealth bundle removes the friction of finding a prescriber who understands off-label SERM use in males.

Dr. Mohit Khera, a urologist at Baylor College of Medicine, has stated: "Clomiphene citrate and its isomers remain one of the most practical options for men who want to raise testosterone without compromising sperm production." This perspective, published in the context of the Endocrine Society's 2018 clinical practice guideline on testosterone therapy 8, helps explain the growing telehealth market around enclomiphene specifically.

How Enclomiphene Compares to Clomiphene (Clomid) on Cost

Generic clomiphene citrate 50 mg tablets carry a GoodRx cash price of roughly $10 to $30 for 30 tablets at major chain pharmacies. That is significantly cheaper than compounded enclomiphene. The clinical question is whether the price difference justifies the pharmacological difference.

Kim et al. (BJU Int, 2016; N=48) demonstrated that enclomiphene citrate 25 mg daily raised mean serum testosterone from 228 ng/dL to 419 ng/dL over 3 months while preserving sperm concentration 1. Racemic clomiphene produces similar testosterone elevations in multiple studies 9, but the zuclomiphene isomer accumulates over time due to its longer half-life (approximately 30 days vs. 10 days for enclomiphene) 2. Zuclomiphene's estrogenic activity has been linked to visual disturbances and mood changes in some patients 10.

A retrospective analysis in Fertility and Sterility found that approximately 20% of men on racemic clomiphene reported side effects significant enough to consider discontinuation 11. Patient forums consistently describe enclomiphene as "cleaner" in subjective feel, with fewer reports of emotional blunting, though these comparisons carry obvious selection bias. Men spending more on enclomiphene may have stronger expectations of tolerability.

What Reddit and Patient Forums Report

Online patient communities provide the largest accessible dataset on real-world enclomiphene experiences, though the data is self-selected and uncontrolled. Across r/Testosterone, r/Trt, and the Drugs.com user review section, recurring themes emerge.

On efficacy, users frequently report testosterone increases of 150 to 300 ng/dL within 4 to 8 weeks on 25 mg daily. This aligns with the clinical data from the Androxal trials, where mean testosterone increases of approximately 200 ng/dL were observed 12. One Reddit user on r/Testosterone described going "from 260 to 480 ng/dL in six weeks on 25 mg," a result consistent with the Kim et al. findings 1.

On cost frustration, the dominant complaint is not the drug price itself but the surrounding expenses: initial bloodwork ($150 to $400 without insurance), follow-up labs every 8 to 12 weeks, and provider consultation fees. The Endocrine Society recommends measuring total testosterone, LH, FSH, and estradiol at baseline and during treatment 8. A complete monitoring panel at a direct-to-consumer lab company runs $80 to $150 per draw.

On side effects, the most commonly mentioned issues are mild headaches, transient visual changes (less frequent than with racemic clomiphene), and occasional acne. Serious adverse events are rarely reported in either the clinical literature or patient forums. A 2014 review in the Journal of Clinical Endocrinology and Metabolism noted that SERMs in men carry a generally favorable safety profile when used at recommended doses 13.

The Endocrine Society's guideline panel has cautioned: "We suggest against using testosterone therapy in men planning fertility in the near term, and suggest clomiphene citrate as an alternative" 8. This recommendation drives many younger men toward enclomiphene specifically, viewing it as the refined version of the guideline's suggested agent.

True Annual Cost: Building the Full Picture

A month of enclomiphene at a compounding pharmacy is only one line item. The realistic first-year cost for a self-pay patient includes the initial consultation ($75 to $250), baseline bloodwork ($150 to $400), the medication ($360 to $1,080 annually at $30 to $90/month), and follow-up labs at three intervals ($240 to $450 total) 14.

That sums to roughly $825 to $2,180 for year one. By comparison, testosterone cypionate injections through a men's health clinic run $1,200 to $2,400 annually when including labs and consultations, but exogenous testosterone suppresses spermatogenesis through negative feedback on the hypothalamic-pituitary-gonadal axis 15. For men who value fertility preservation, the cost comparison is not straightforward. Adding human chorionic gonadotropin (hCG) to a TRT protocol to maintain testicular function adds another $80 to $200 per month 16.

The total cost of a TRT-plus-hCG protocol ($2,160 to $4,800 annually) frequently exceeds enclomiphene monotherapy, making enclomiphene the less expensive option for men who need both testosterone support and preserved fertility. The European Association of Urology's guidelines on male hypogonadism similarly note that SERMs avoid the fertility trade-off inherent to exogenous androgens 17.

Strategies to Reduce Out-of-Pocket Cost

Price shopping between compounding pharmacies is the single highest-yield strategy. A 2021 JAMA Internal Medicine study found that compounding pharmacy prices for the same formulation varied by as much as 300% between providers 18. Requesting a 90-day supply instead of 30-day fills often reduces per-unit cost by 10% to 20%.

Patients can also ask their prescriber about 12.5 mg dosing. The Androxal Phase III trials tested both 12.5 mg and 25 mg doses, with both producing statistically significant testosterone elevation above placebo 12. If 12.5 mg achieves the patient's target testosterone level (the Endocrine Society defines the lower normal limit as 264 ng/dL using a standardized LC-MS/MS assay) 8, the lower dose halves medication cost.

Using direct-to-consumer lab services (Quest via apps, or standalone lab companies) instead of hospital-based draws can cut monitoring costs by 40% to 60%. The AUA guidelines note that testosterone monitoring requires LC-MS/MS methodology for accuracy, so patients should confirm their lab uses this method rather than immunoassay 19.

A final option: some patients use racemic clomiphene 25 mg (half a standard 50 mg tablet) as a lower-cost substitute, accepting the zuclomiphene exposure. This approach has clinical support in the literature 9 but lacks the isomer-specific tolerability profile that motivates the enclomiphene premium.

Insurance and Prior Authorization: The Current Reality

Commercial insurance does not cover compounded enclomiphene. Period. Without an FDA-approved NDA product and corresponding NDC, there is no pathway for formulary inclusion 4. Some men have had success getting racemic clomiphene (Clomid) covered off-label for male hypogonadism through prior authorization, particularly with documentation of secondary hypogonadism and fertility goals 20.

Health savings account (HSA) and flexible spending account (FSA) funds can be used for compounded enclomiphene when prescribed by a licensed provider for a diagnosed medical condition. The IRS considers compounding pharmacy charges an eligible medical expense 14. Men should keep the prescription, receipt, and a brief letter of medical necessity from their prescriber for potential audit documentation.

If an FDA-approved enclomiphene product reaches market (several pharmaceutical companies have active IND applications), insurance dynamics would change rapidly. An approved product would receive an NDC, enabling formulary review and potential Tier 2 or Tier 3 coverage. Until then, every dollar comes from the patient's pocket.